<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 5, 2000
Jayark Corporation
(Exact name of registrant as specified in its charter)
Delaware 0-3255 13-1864519
(State of incorporation) (Commission File#) (IRS EIN)
Post Office Box 741528, Houston, Texas 77274
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including are code: 713-783-9184
N/A
(Former name or former address, if changed since last report.)
<PAGE>
Item 5. Other Events
On January 5, 2000 Jayark Corporation (the "Company"), through a
newly formed, wholly owned subsidiary, Fisher Medical Corporation
("Fisher"), entered into an Asset Purchase Agreement with Fisher
Medical, LLC, a company that develops, manufactures and distributes
medical supplies and equipment for hospitals, nursing homes and
individuals. Under the terms of the agreement, Fisher purchased all
of the assets of Fisher Medical, LLC for cash of $215,000. Fisher
then entered into Employment Agreements with the two principals of
Fisher Medical, LLC to continue developing, manufacturing and
distributing medical products of Fisher. In consideration for the
Employment Agreements, the two principals also entered into Non-
Disclosure and Non-Competition Agreements. Fisher financed this
purchase from the Company's existing $1,250,000 revolving line of
credit.
If Fisher can develop, manufacture and distribute medical supplies
and equipment, the income and cash flow could have a material affect
on the operating results of Jayark Corporation. There can be no
assurances that the Company will be successful in this venture.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
JAYARK CORPORATION
Registrant
By: /s/ David L. Koffman Dated: January 5, 2000
President, Chief Executive Officer
<PAGE>
